Patient Square Capital LP Liquidia Corp Transaction History
Patient Square Capital LP
- $277 Billion
- Q2 2025
A detailed history of Patient Square Capital LP transactions in Liquidia Corp stock. As of the latest transaction made, Patient Square Capital LP holds 1,020,000 shares of LQDA stock, worth $24.6 Million. This represents 4.58% of its overall portfolio holdings.
Number of Shares
1,020,000
Previous 1,522,452
33.0%
Holding current value
$24.6 Million
Previous $22.5 Billion
43.4%
% of portfolio
4.58%
Previous 9.29%
Shares
4 transactions
Others Institutions Holding LQDA
# of Institutions
209Shares Held
47.4MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$102 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$102 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$86.6 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$72.3 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$59.6 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.55B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...